The pathogenic role of a placenta-specific protease in early-onset preeclampsia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1108365

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Preeclampsia (PE) is a life-threatening disorder of pregnancy. If left untreated, PE will lead to maternal as well as fetal death. Unfortunately, the only current effective “cure” for PE is to deliver the baby prematurely. The causes of PE are intrinsically related to the placenta, the organ that connects the fetus to the mother. This project will investigate a unique enzyme that is produced only by the placenta, its contribution to PE and its potential as a target for PE treatment.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $601,950.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

placenta | placental insufficiency | pre-eclampsia | pregnancy complications | protease

Related Links